Skip to main content

Ocrelizumab

Prolonged severe acute respiratory syndrome Coronavirus-2 infection: case report

This is a preview of subscription content, access via your institution.

Reference

  • Gibson EG, et al. Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis. Open Forum Infectious Diseases 8: No. 7, Jul 2021. Available from: URL: http://doi.org/10.1093/ofid/ofab176

Download references

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ocrelizumab. Reactions Weekly 1901, 388 (2022). https://doi.org/10.1007/s40278-022-13065-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-13065-y